New program aims to help parents with advanced cancer support their kids

NCT ID NCT05477784

Terminated Symptom relief Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two educational programs for parents with late-stage cancer who have children aged 5 to 17. The programs were designed to improve parent-child relationships and boost parents' confidence in talking about cancer with their kids. Researchers hoped to reduce anxiety and depression in both parents and children. The trial was terminated early, so the full results are not available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Educational program
What this could lead to: If successful, this program could provide a practical way to help parents with advanced cancer support their children's emotional health and reduce family distress.
What could go wrong: The trial was terminated early, so results may be limited. The programs are educational and may not work for all families or change medical outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER HEMATOPOIETIC AND LYMPHOID SYSTEM NEOPLASM MALIGNANT SOLID NEOPLASM PARENT-CHILD RELATIONS PARENTING SURVIVORSHIP

Contacts and locations

Locations

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98115, United States
Georgetown University

Washington D.C., District of Columbia, 20007, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.